FI970526L - Estra-1,3,5(10)-trieenijohdannaiset, niiden valmistusmenetelmät sekä näitä yhdisteitä sisältävät farmaseuttiset koostumukset - Google Patents

Estra-1,3,5(10)-trieenijohdannaiset, niiden valmistusmenetelmät sekä näitä yhdisteitä sisältävät farmaseuttiset koostumukset Download PDF

Info

Publication number: FI970526L
Authority: FI; Finland
Prior art keywords: estra; compounds; preparation; methods; pharmaceutical compositions
Prior art date: 1994-08-09

Application number

FI970526A

Other languages

English (en)

Swedish (sv)

Other versions

FI970526A7 (fi

FI970526A0 (fi

Inventor

Sigfrid Prof Dr Schwarz

Walter Dr Elger

Hans-Joachim Dr Siemann

Gudrun Reddersen

Birgitt Schneider

Original Assignee

Jenapharm Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-08-09

Filing date

1995-07-03

Publication date

1997-02-07

1995-07-03 Application filed by Jenapharm Gmbh filed Critical Jenapharm Gmbh

1997-02-07 Publication of FI970526A7 publication Critical patent/FI970526A7/fi

1997-02-07 Publication of FI970526A0 publication Critical patent/FI970526A0/fi

1997-02-07 Publication of FI970526L publication Critical patent/FI970526L/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
- C07J53/004—3 membered carbocyclic rings

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Endocrinology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

FI970526A 1994-08-09 1995-07-03 Estra-1,3,5(10)-trieenijohdannaiset, niiden valmistusmenetelmät sekä näitä yhdisteitä sisältävät farmaseuttiset koostumukset FI970526L (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE4429397A DE4429397C2 (de)	1994-08-09	1994-08-09	Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
PCT/DE1995/000877 WO1996005216A1 (de)	1994-08-09	1995-07-03	Estra-1,3,5(10)-trien-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen

Publications (3)

Publication Number	Publication Date
FI970526A7 FI970526A7 (fi)	1997-02-07
FI970526A0 FI970526A0 (fi)	1997-02-07
FI970526L true FI970526L (fi)	1997-02-07

Family

ID=6526060

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI970526A FI970526L (fi)	1994-08-09	1995-07-03	Estra-1,3,5(10)-trieenijohdannaiset, niiden valmistusmenetelmät sekä näitä yhdisteitä sisältävät farmaseuttiset koostumukset

Country Status (21)

Country	Link
US (1)	US6080735A (fi)
EP (3)	EP0775155B1 (fi)
JP (1)	JP3814292B2 (fi)
CN (1)	CN1057305C (fi)
AT (2)	ATE482968T1 (fi)
AU (1)	AU699701B2 (fi)
BR (1)	BR9508864A (fi)
CA (1)	CA2196694A1 (fi)
CZ (1)	CZ288762B6 (fi)
DE (3)	DE4429397C2 (fi)
DK (1)	DK0775155T3 (fi)
ES (1)	ES2220932T3 (fi)
FI (1)	FI970526L (fi)
HU (1)	HUT77610A (fi)
IL (1)	IL114779A (fi)
NZ (1)	NZ289793A (fi)
PL (1)	PL186185B1 (fi)
PT (1)	PT775155E (fi)
RU (1)	RU2139885C1 (fi)
SG (1)	SG47348A1 (fi)
WO (1)	WO1996005216A1 (fi)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19712488A1 (de) *	1997-03-25	1998-10-01	Knoell Hans Forschung Ev	Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben
DE19753363A1 (de) *	1997-12-02	1999-06-10	Jenapharm Gmbh	15-Methyl-cyclopropanosteroide und Verfahren zu ihrer Herstellung
DE59907446D1 (de) *	1998-02-20	2003-11-27	Schering Ag	Pharmazeutische präparate zur gezielten substitution des estrogenmangels im zentralnervensystem
US6245756B1 (en)	1998-02-27	2001-06-12	Jenapharm Gmbh & Co. Kg	Pharmaceutical preparations for treatment of estrogen deficiency in the central nervous system
DE19834931A1 (de) *	1998-07-28	2000-02-24	Jenapharm Gmbh	Verwendung von biogenen Estrogenen zur Hormonsubstitutionstherapie
DE19906152B4 (de)	1999-02-10	2005-02-10	Jenapharm Gmbh & Co. Kg	Wirkstoffhaltige Laminate für Transdermalsysteme
SI20853A (sl)	1999-08-31	2002-10-31	Jenapharm Gmbh & Co. Kg	Mezoprogestini (modulatorji receptorja progesterona) kot sestavina ženskih kontraceptivov
US6653298B2 (en)	2000-01-14	2003-11-25	Sterix Limited	Composition
US7335650B2 (en) *	2000-01-14	2008-02-26	Sterix Limited	Composition
DE10027887A1 (de)	2000-05-31	2001-12-13	Jenapharm Gmbh	Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
GB0020498D0 (en)	2000-08-18	2000-10-11	Sterix Ltd	Compound
ES2287184T3 (es) *	2000-11-03	2007-12-16	Washington University	Estructuras aromaticas modificadas con sustituyentes hidroxi-, que tienen actividad citoprotectora.
WO2002040032A2 (en) *	2000-11-17	2002-05-23	Washington University	Cytoprotective estrogen derivatives
DE10139494A1 (de) *	2001-08-13	2003-03-06	Jenapharm Gmbh	Antitumor wirksame 2-Alkoxyestradiolsulfamate
US8026229B2 (en)	2001-08-13	2011-09-27	Sterix Limited	Antitumor-active 2-alkoxyestradiol sulfamates
RU2238095C2 (ru) *	2002-11-12	2004-10-20	Эндокринологический научный центр РАМН	Состав, обладающий контрацептивной активностью
DE10307105A1 (de) *	2003-02-19	2004-09-09	Schering Ag	Antitumor wirksame 2-substituierte 18a-Homoestra-1,3,5(10)-trien-3-yl sulfamate
DE10307104A1 (de)	2003-02-19	2004-09-23	Schering Ag	Antitumor wirksame 2-substituierte Estra-1,3,5(10)-trien-3-yl sulfamate
DE10307103A1 (de) *	2003-02-19	2004-09-09	Schering Ag	Antitumor wirksame 2-substituierte D-Homostra-1,3,5(10)-trien-3-yl sulfamate
CA2518506A1 (en) *	2003-03-13	2004-11-18	Nitromed, Inc.	Nitrosated and nitrosylated compounds, compositions and methods of use
US7534780B2 (en)	2004-05-21	2009-05-19	Bayer Schering Pharma Aktiengesellschaft	Estradiol prodrugs
US20060183725A1 (en) *	2005-02-15	2006-08-17	Thomas Graeser	Pharmaceutical preparation for oral contraception
EP2149371A1 (en)	2008-07-28	2010-02-03	PregLem S.A.	Use of steroid sulfatase inhibitors for the treatment of preterm labor
GB201302368D0 (en) *	2013-02-11	2013-03-27	Univ Bath	Compound
RU2667942C2 (ru)	2013-07-11	2018-09-27	Эвестра, Инк.	Соединения, образующие пролекарства
CN105753924B (zh) *	2016-02-03	2017-11-10	中国药科大学	新型甾体类选择性雌激素受体调节剂、其制备方法及其医药用途
US10624903B2 (en)	2017-10-19	2020-04-21	Evestra, Inc.	Longer-acting progestin prodrug contraceptives

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2133484A2 (en) *	1969-04-29	1972-12-01	Jenapharm Veb	3-17 and 21-sulphonyloxy-steroids - with androgenic anabolic progestogenic and oestrogen activity of long duration
GB1317373A (en) *	1971-03-11	1973-05-16	Jenapharm Veb	Steroid esters
US3697558A (en) *	1971-03-24	1972-10-10	Lilly Co Eli	Preparation of 17alpha-ethynylestriol
GB1398026A (en) *	1972-11-10	1975-06-18	Jenapharm Veb	Steroid esters
DD114806A1 (fi) *	1974-10-11	1975-08-20
DD145919B1 (de) *	1978-06-28	1982-06-30	Kurt Ponsold	Verfahren zur herstellung von 14,1 -methylenderivaten der oestranreihe
DD201143B1 (de) *	1981-11-17	1986-12-17	Jenapharm Veb	Verfahren zur herstellung von 9,11-tritiummarkierten gonatriensulfonaten
DD207447A3 (de) *	1982-04-02	1984-02-29	Jenapharm Veb	Mittel zur chemosterilisation von schadnagetieren
FR2533570B1 (fr) *	1982-09-23	1985-07-12	Centre Nat Rech Scient	Complexes organometalliques d'oestrogenes et leur application au dosage des recepteurs hormonaux
RU2087479C1 (ru) *	1989-11-29	1997-08-20	Шеринг Аг	Эстратриены, содержащие мостик
GB9118478D0 (en) *	1991-08-29	1991-10-16	Imperial College	Steroid sulphatase inhibitors
DE4222316A1 (de) *	1992-07-03	1994-01-05	Schering Ag	Verfahren zur Herstellung von Etheno- und Ethano-16â,17µ-Steroiddiolen und deren Derivaten

1994
- 1994-08-09 DE DE4429397A patent/DE4429397C2/de not_active Expired - Fee Related
1995
- 1995-07-03 EP EP95925679A patent/EP0775155B1/de not_active Expired - Lifetime
- 1995-07-03 EP EP02090252A patent/EP1284273B1/de not_active Expired - Lifetime
- 1995-07-03 DE DE59511110T patent/DE59511110D1/de not_active Expired - Lifetime
- 1995-07-03 ES ES95925679T patent/ES2220932T3/es not_active Expired - Lifetime
- 1995-07-03 BR BR9508864A patent/BR9508864A/pt not_active IP Right Cessation
- 1995-07-03 AT AT02090252T patent/ATE482968T1/de active
- 1995-07-03 DK DK95925679T patent/DK0775155T3/da active
- 1995-07-03 NZ NZ289793A patent/NZ289793A/en unknown
- 1995-07-03 WO PCT/DE1995/000877 patent/WO1996005216A1/de not_active Ceased
- 1995-07-03 AU AU29741/95A patent/AU699701B2/en not_active Ceased
- 1995-07-03 CZ CZ1997274A patent/CZ288762B6/cs not_active IP Right Cessation
- 1995-07-03 PT PT95925679T patent/PT775155E/pt unknown
- 1995-07-03 RU RU97104003/04A patent/RU2139885C1/ru not_active IP Right Cessation
- 1995-07-03 US US08/750,943 patent/US6080735A/en not_active Expired - Lifetime
- 1995-07-03 EP EP02090253A patent/EP1273590A3/de not_active Withdrawn
- 1995-07-03 JP JP50354196A patent/JP3814292B2/ja not_active Expired - Lifetime
- 1995-07-03 AT AT95925679T patent/ATE266038T1/de active
- 1995-07-03 CA CA002196694A patent/CA2196694A1/en not_active Abandoned
- 1995-07-03 DE DE59510900T patent/DE59510900D1/de not_active Expired - Lifetime
- 1995-07-03 FI FI970526A patent/FI970526L/fi not_active IP Right Cessation
- 1995-07-03 HU HU9700389A patent/HUT77610A/hu unknown
- 1995-07-03 PL PL95318525A patent/PL186185B1/pl not_active IP Right Cessation
- 1995-07-03 CN CN95194914A patent/CN1057305C/zh not_active Expired - Fee Related
- 1995-07-27 SG SG1995000954A patent/SG47348A1/en unknown
- 1995-07-30 IL IL11477995A patent/IL114779A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0775155B1 (de)	2004-05-06
FI970526A7 (fi)	1997-02-07
FI970526A0 (fi)	1997-02-07
PT775155E (pt)	2004-09-30
ATE482968T1 (de)	2010-10-15
CA2196694A1 (en)	1996-02-22
EP1273590A3 (de)	2004-07-28
RU2139885C1 (ru)	1999-10-20
DE59511110D1 (de)	2010-11-11
PL186185B1 (pl)	2003-11-28
DE4429397A1 (de)	1996-02-15
SG47348A1 (en)	1998-04-17
DE59510900D1 (de)	2004-06-09
US6080735A (en)	2000-06-27
CN1156998A (zh)	1997-08-13
BR9508864A (pt)	1997-11-11
AU2974195A (en)	1996-03-07
PL318525A1 (en)	1997-06-23
AU699701B2 (en)	1998-12-10
IL114779A (en)	2003-06-24
HUT77610A (hu)	1998-06-29
NZ289793A (en)	1998-11-25
DK0775155T3 (da)	2004-08-30
JPH10503180A (ja)	1998-03-24
CN1057305C (zh)	2000-10-11
EP1273590A2 (de)	2003-01-08
JP3814292B2 (ja)	2006-08-23
EP1284273B1 (de)	2010-09-29
WO1996005216A1 (de)	1996-02-22
EP1284273A2 (de)	2003-02-19
IL114779A0 (en)	1995-11-27
ES2220932T3 (es)	2004-12-16
EP0775155A1 (de)	1997-05-28
ATE266038T1 (de)	2004-05-15
CZ27497A3 (en)	1997-08-13
DE4429397C2 (de)	2003-11-20
EP1284273A3 (de)	2004-07-21
CZ288762B6 (cs)	2001-08-15

Similar Documents

Publication	Publication Date	Title
FI970526L (fi)	1997-02-07	Estra-1,3,5(10)-trieenijohdannaiset, niiden valmistusmenetelmät sekä näitä yhdisteitä sisältävät farmaseuttiset koostumukset
IL136938A0 (en)	2001-06-14	11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
HUP9900974A3 (en)	2000-09-28	Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them
HUP0001508A3 (en)	2003-01-28	4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them
EE9500064A (et)	1996-06-17	Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid
HUP0203542A3 (en)	2003-07-28	3(5)-amino-pyrazole derivatives, process for their preparation, their use and pharmaceutical compositions containing the same
HUP9700358A3 (en)	1999-08-30	New oxazolidinon derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0001555A3 (en)	2001-01-29	Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
ZA962916B (en)	1996-10-14	New arylglycineamide derivatives processes for the manufacture thereof and pharmaceutical compositions containing these compounds
HUP0000901A3 (en)	2001-07-30	16-hydroxy-11(substituted phenyl)-estra-4,9-diene derivatives, process for their preparation and pharmaceutical compositions containing them
FI952550A7 (fi)	1995-11-28	Uudet N-pyridyylikarboksamidit ja johdannaiset, menetelmät niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
IL113103A0 (en)	1995-06-29	Piperidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
EE9900112A (et)	1999-10-15	2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
HUP9901485A3 (en)	2001-03-28	Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use
GR3034582T3 (en)	2001-01-31	Substituted 4-phenyl thiazole derivatives, process for their preparation and pharmaceutical compositions containing them
FI960316L (fi)	1996-03-22	Oksatiolaanit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
HUP9904526A3 (en)	2000-12-28	Piperidine derivatives, process for their preparation and pharmaceutical compositions containing the same
HUP0102609A3 (en)	2002-12-28	N-phenyl-n'-phenylpropylpiperazine derivatives and process for the preparation thereof, and pharmaceutical compositions containing them
FI951091A7 (fi)	1995-09-12	Uudet alkyyliaminoindaaniyhdisteet, menetelmät niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
HUP9801068A3 (en)	2000-02-28	1,2,3,4-tetrahydro-2-naphtaleneamine derivatives, process for their preparation, their use, and pharmaceutical compositions containing them
IL119603A (en)	2000-10-31	Amidinohydrazone derivatives methods for the preparation thereof and pharmaceutical compositions containing the same
HUP9702477A3 (en)	1999-06-28	New polymorphous form of doxazosin-mesylate (form iii), process for it's preparation and pharmaceutical compositions containing the same
HUP0003104A3 (en)	2002-01-28	Amino-spiropiperidin-quinazoline derivatives, their use, process for their preparation and pharmaceutical compositions containing them
IL115981A0 (en)	1996-01-31	Cyclolignan derivatives procosses for the preparation thereof and pharmaceutical compositions containing the same
FI972129A0 (fi)	1997-05-19	6-metoksi-1H-bentsotriatsoli-5-karboksamidijohdannaisia, menetelmä niiden valmistamiseksi ja niitä sisältäviä lääkekoostumuksia

Legal Events

Date	Code	Title	Description
2005-01-31	MA	Patent expired